Following the (mAb) leader: leveraging monoclonal antibody cell line development & banking CMC strategies for iPSC-derived cell therapies
Cell & Gene Therapy Insights 2024; 10(1), 29–33
DOI: 10.18609/cgti.2024.005
Published: 17 January
Viewpoint